mobile-menu-icon
GM Authority

General Motors China Sales Up 7.8 Percent To 313,283 Units March 2014

Sales of General Motors vehicles and those of GM’s joint venture partners in China grew 7.8 percent to 313,283 units for the month of March 2014.

Shanghai GM

Shanghai GM, the primary joint venture (between General Motors and China’s SAIC) responsible for sales of Chevrolet, Buick, and Cadillac vehicles, sold 140,077 vehicles in March, a 10.5 percent year-over-year increase.

Buick sales in the domestic Chinese market rose 12.4 percent year-over-year to 78,803 units. The original Excelle family continued to lead the pace for the Tri-Shield brand with 26,220 units sold. The Excelle XT and GT followed closely with 23,015 sales, a 38.2 percent growth year-over-year. Meanwhile, sales of the Regal grew 4.5 percent year-over-year to 8,626 units.

Chevrolet sales grew 5.7 percent on an annual basis to 56,036 units. With 22,351 units sold (up 39.6 percent), the Cruze continued its streak as the best-selling Chevy in China, followed by the Sail, with 17,885 units sold.

Meanwhile, Cadillac sales totaled 5,238 units, a 44.3 percent increase on a year-over-year basis. The XTS remained the most popular model, selling 2,459 units, with the SRX following at 2,363 units, up 54.2 percent.

SAIC-GM-Wuling (And Baojun)

Sales of SAIC-GM-Wuling rose 6.1 percent to a March record 164,539 units. Of those, domestic sales of the Wuling commercial van and truck brand rose 15.1 percent from last March to 159,729 units, with the Hong Guang line of vans seeing a 27.6 percent increase in sales to 63,827 units. Sales of the Baojun entry-level passenger car brand, meanwhile, totaled 4,810 units in March.

FAW-GM

FAW-GM’s domestic sales rose 2.2 percent to 8,556 units.

Former staff.

Subscribe to GM Authority

For around-the-clock GM news coverage

We'll send you one email per day with the latest GM news. It's totally free.

Comment

  1. GM to continue exploiting and developing good cars for the Chinese market; and that after this development will go to the USA market

    It’s the best they can do

    Regards from Spain

    Reply

Leave a comment

Cancel